Physician Assistant · Birmingham, AL
NPI
1114298510
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2100 16th Avenue South, 202
Birmingham, AL, 35205
Phone (205) 933-0987
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,512 services
Medicare patients, 2024
481
Average age 75
Drug cost, 2024
$2.4M
1,840 prescriptions
Company payments, 2025
$126K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalie E George was code 17003 (destruction skin lesion), 901 times for 144 patients. In total Natalie E George billed 2,512 services in 46 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 901 | 144 | $3.38 | $3,046 |
| 99213 Office E&M - Established | Office | 436 | 330 | $45.03 | $20K |
| 17000 Destruction Skin Lesion | Office | 233 | 183 | $24.61 | $5,735 |
| 11102 Skin Biopsy | Office | 188 | 160 | $42.86 | $8,057 |
| 17110 Destruction Skin Lesion | Office | 161 | 134 | $54.36 | $8,752 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 74 | 23 | $0.63 | $46.74 |
| 99212 Office E&M - Established | Office | 65 | 58 | $26.91 | $1,749 |
| 11103 Skin Biopsy | Office | 64 | 44 | $28.65 | $1,834 |
| 99203 Office E&M - New | Office | 62 | 62 | $47.72 | $2,959 |
| 99214 Office E&M - Established | Office | 55 | 42 | $58.10 | $3,195 |
| 17004 Destruction Skin Lesion | Office | 32 | 29 | $81.66 | $2,613 |
| 11300 Removal or Shaving of Skin Growth | Office | 24 | 21 | $35.02 | $841 |
| 11301 Removal or Shaving of Skin Growth | Office | 23 | 23 | $62.91 | $1,447 |
| 99202 Office E&M - New | Office | 19 | 19 | $34.67 | $659 |
| 96372 Injection Administration | Office | 18 | 15 | $7.22 | $130 |
By year: 2022 $115K for 3,300 services; 2023 $67K for 2,304 services; 2024 $71K for 2,512 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natalie E George prescribed most often to Medicare patients was Clobetasol Propionate, with 250 prescriptions and refills. In total Natalie E George wrote 1,840 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 250 | 254 | 160 | $12K |
| Fluorouracil Generic | 216 | 216 | 185 | $20K |
| Triamcinolone Acetonide Generic | 143 | 148 | 103 | $2,516 |
| Ketoconazole Generic | 125 | 125 | 73 | $3,130 |
| Hydrocortisone Generic | 120 | 120 | 89 | $702 |
| Doxycycline Hyclate Generic | 95 | 118 | 27 | $2,294 |
| Taltz Autoinjector Ixekizumab | 76 | 76 | Under 11 | $512K |
| Dupixent Pen Dupilumab | 71 | 71 | Under 11 | $264K |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 55 | 55 | 32 | $3,032 |
| Betamethasone Dipropionate Generic | 51 | 51 | 29 | $1,805 |
| Valacyclovir Valacyclovir Hcl | 47 | 59 | 16 | $1,274 |
| Clindamycin Phosphate Generic | 47 | 49 | 27 | $1,264 |
| Minocycline Hcl Generic | 42 | 42 | 31 | $1,279 |
| Tacrolimus Generic | 41 | 43 | 17 | $9,114 |
| Rinvoq Upadacitinib | 40 | 40 | Under 11 | $250K |
Brand drugs: 343 claims; generic drugs: 1,497 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natalie E George $126K ($126K in general payments such as food, travel and fees) from 22 companies. The largest payer was Organon LLC with $29K.
| Company | Payments | Amount |
|---|---|---|
| Organon LLC OGN | 73 | $29K |
| Lilly USA, LLC LLY | 41 | $22K |
| Abbvie Inc. ABBV | 64 | $20K |
| Incyte Corporation INCY | 42 | $14K |
| Genzyme Corporation SNY | 19 | $12K |
| Regeneron Healthcare Solutions, Inc. REGN | 28 | $11K |
| Janssen Biotech, Inc. JNJ | 33 | $10K |
| UCB, Inc. UCB.BR | 14 | $5,230 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $682 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $410 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.